In the determination of specific binding in re ceptor binding techniques in vitro as well as in vivo, de termination of the nonspecific binding as well as the free component is of crucial importance. If a low proportion of specific binding is included when determining the nonspe cific binding, relatively large errors may be obtained. In the present study, benzodiazepine (BZ) receptor binding in the human brain was determined in vivo using position emission tomography (PET) by applying a saturation pro cedure using [11C]flumazenil as an example of this prob lem. Analysis of the errors in B m ax and Kn obtained using
Many receptor binding studies in the brain in vitro and in vivo are aimed at determining the num ber of binding sites (Bmax) and affinity (Ko) of the receptor, usually using saturation analyses. An ex act analysis of the nonspecific binding as well as the free component is thereby of crucial importance. If specific binding is included when determining non specific binding, relatively large errors may be ob tained in the estimation, even though the density of specific binding in this reference region is only a few percent of that in the target region.
Benzodiazepine (BZ) receptor binding in the hu man brain using positron emission tomography (PET) is often studied by performing a saturation procedure with the radioligand [ 1l C]flumazenil (Ma ziere et aI., 1983; Ehrin et aI., 1984; Halldin et aI., Scatchard analysis in PET was performed using a priori information from in vitro [3H]flumazenil binding in the pons, used normally as a reference region in BZ receptor binding studies. Even if the density of BZ receptors in the reference region pons is only 2% compared to that in the frontal cortex, this small proportion of specific binding sites will result in a 10% error in the B m ax and Kn values. Simulation of a number of Scatchard plots was performed at varying ratios between the nonspecific and the specific binding. Key Words: Benzodiazepine-Positron emission tomography-Receptor binding-Scatchard analysis.
1988). As a region defining nonspecific binding and free radioligand, the pons or white matter is chosen as the reference region (Savic et al., 1988; Persson et aI., 1989 Persson et aI., , 1991 Abadie et aI, 1992; Litton et aI., 1993) . One great advantage of using the pons as the reference region is that the pons region-of-interest (ROI) is anatomically easy to define in the PET or magnetic resonance imaging (MRI) image. The pons can also be measured with full tissue recovery, without any partial volume effects (Hoffman et aI., 1979; Litton et aI., 1984) ; this may not be the case with white matter in other parts of the brain. When using the pons as an estimate of free and nonspe cifically bound radioligand, one assumes no or in significant levels of BZ receptors in this region.
However, there are a small number of BZ receptors in the pons (Hall et aI., 1992) , which makes it an imperfect region for the estimation of free and non specifically bound radioligand.
In the present study, the errors in measured PET values for Bmax, Ko' and BIF (binding potential at a high specific activity, where B = specifically bound and F = free radioligand) were estimated using sat uration analysis with Scatchard plots (Scatchard, 1949) , applying results from in vitro [ 3 H]flumazenil binding to the pons in homogenates from human brain. Simulations of Scatchard plots were also per formed to illustrate the errors obtained in these pa rameters with different amounts of binding sites in the reference region. The results are also discussed from a theoretical point of view.
METHODS
The target regions and pons were drawn as ROIs on a proton density-weighted MRI image and overlaid upon the PET image, which was obtained using a Scanditronix PC2048-15B brain tomograph (Litton et ai., 1990) .
To standardize the positioning of the pons area, this region was always chosen to be in the MRI slice in which the pituitary fossa region and the fourth ventricle could be identified. The same regions were identified and used for in vitro [3H]flumazenil binding to homogenates from post mortem human brain. The studies have been published elsewhere (Hall et ai., 1992; Litton et ai., 1993) , where detailed descriptions of the methods and results are given.
For the quantification of receptor-ligand binding in PET, a saturation procedure with two experiments in the same subject was performed with widely different spe cific radioactivities, one high and the second low. The radioactivity values at equilibrium were used to create a two-point Scatchard plot (B I F vs. B) to determine the number of specific binding sites, B m a x , the equilibrium dissociation constant, K D , and the B I F. To estimate the error from the PET measurement, the B m a x values from in vitro eH]flumazenil binding from pons homogenates were used and the analysis was repeated.
Determinations of Band F and thus of B I F, were per formed applying varying ratios between B m a x( reference reo gion) and B m a x( tar ge t region) according to the following equa tions:
is the concentration of specifically bound ra dioligand in tissue (nCilml), C rC t) is the concentration of free and nonspecifically bound radio ligand in tissue (nCil ml), te is the equilibrium time point (min), and SA is the specific activity. A number of determinations of Band B I F with varying F values are shown in the figures.
RESULTS
The Bmax values obtained in PET are of the same order of magnitude as those obtained earlier in re ceptor binding studies in vitro (Hall et al. , 1992) .
The density of BZ receptors in the pons is approx imately 2 pmollg wet weight tissue as shown by the in vitro receptor binding studies, whereas the den-sities in cortical and cerebellar regions vary from 30
to 90 pmol/g using either of the techniques. The Ko values are expressed differently in vivo and in vitro (the value obtained in PET is expressed as pico moles per milliliter of tissue, while that of the in vitro studies is expressed as the nanomolar concen tration), as the in vivo concentration of the radioli gand at the receptor cannot be determined directly.
It is thus not possible to compare directly the affin ity constants obtained in vivo and in vitro.
Assuming a Bmax value in the target region (e.g. , cerebral cortex) of 90 pmol/g and a Ko of 25 pmollml and using the in vitro for the pons (Bmax = 2 pmollg, Ko = 25 pmollml), three lines are plotted in the Scatchard plot-the measured (assumed) plot, the pons plot, and the correct plot, which was adjusted for the pons data ( Fig. O . A pons value of 2 pmollg will underestimate the cortical Bmax obtained in PET by up to 9% and the Ko by 11%. The BIF will be overestimated by up to 6%.
Simulated theoretical Scatchard plots are drawn assuming 0, 1, 2, 5, 10, or 15% receptors in the reference region compared to the target region ( Fig.   2a ). For example, assuming a reference region value of 5% that in the target region, a Scatchard plot will underestimate the Bmax by up to 12% and the Ko by up to 25% and overestimate the BI F by up to 17%.
The errors in the results are also dependent on the Ko value, as lower values (higher affinities) in crease the errors obtained. In Fig. 2b The Bmax in the target region was set at 100 pmol/g. The resulting Bmax values in the uncorrected plots were 96.7, 93.3, and 83.2 pmol/g, and the Ko values were 8.9,7.8, and 4.8 pmol/ml for 1, 2, and 5%, respectively. 0, 1, 2, and 5% receptors in the reference region compared with the target region. In this case, the receptor density in the reference region being 5% that in the target region, a linear Scatchard plot will underestimate the Bmax by up to 17% and the K D by up to 63% and overestimate the B/F by up to 74%.
DISCUSSION
The use of a reference region in PET has its ad vantages and disadvantages (Blomqvist et al., J Cereb Blood Flow Metab, Vol. 14, No.2, 1994 . A number of assumptions must be made to justify the use of a reference region. For example, the distribution and kinetics of a ligand to and within the compartments of a region must be com parable to those in ROI; if not, the time courses may differ. Even if the rate constants are the same in the target region and reference region, the time courses are expected to differ. In the target region, the processes of specific binding and outflow across the blood-brain barrier compete, in contrast to the reference region.
In the present analysis, the errors in receptor binding using Scatchard analysis in PET were de terminated using a priori information from in vitro eH]flumazenil binding to the reference region pons.
This study has dealt only with errors obtained when using an imperfect reference region, i.e., a region with a low density of specific binding sites of the same kind as those to be studied in the target re gion.
As reported previously (Hall et al., 1992) , the pons region has only about 2% BZ receptors com pared with frontal cortex. However, this low den sity of binding sites in the reference region will re sult in an approximately 10% error in the determi nation of Bmax and K D in the target region when using Scatchard analysis. A higher density or affin ity of receptors in the reference region will result in even larger errors.
The result discussed here is also valid for the measurement of a reference region that is affected by partial volume errors in the PET measurement.
Partial volume errors denote the contrast of a region that only partially occupies the thickness of the to mographic plane. The error, or spillover of gray matter into white matter, in estimating the free and nonspecific binding can be of vital importance.
It is of great importance for the validity of the data obtained to choose a reference region devoid of any specific binding or at least, with < 1 % of that in the ROI. It is unfortunately not possible to com pensate easily for the specific binding in the refer ence region, since the errors obtained are depen dent not only upon the fraction of specific binding in the ROI, but also upon other factors, for example, upon the specific activity of the radioligand. It is thus of great importance to study the reference re gion carefully with regard to the presence of spe cific binding sites for the radioligand that is used.
In conclusion, the determination of specific bind ing in PET studies using an imperfect region for the determination of free and nonspecific binding may result in relatively large errors in Bmax and K D , even if the density of specific binding in this region is only a few percent of that in the target region.
